USANA Health Sciences Inc
XMUN:USJ

Watchlist Manager
USANA Health Sciences Inc Logo
USANA Health Sciences Inc
XMUN:USJ
Watchlist
Price: 12.9 EUR Market Closed
Market Cap: €478.3m

USANA Health Sciences Inc
Investor Relations

USANA Health Sciences makes and sells nutritional supplements, vitamins, meal-replacement products, and personal care items. Its core business is health and wellness products designed for everyday use, with a strong focus on dietary supplements and targeted nutrition. The company does not rely on traditional big-box retail the way many consumer brands do. USANA sells mainly through a direct-selling model. Independent distributors and preferred customers buy the products and often resell them or use them themselves, which gives the company a network-driven route to market. The main customers are health-conscious consumers and the distributors who build sales businesses around the brand. USANA makes money by selling products through this network, with recurring purchases from loyal customers and distributors forming the base of the business. Its role in the industry is different because it sits between a consumer brand and a direct-sales organization: it formulates and manufactures wellness products, then depends on its sales force to reach buyers rather than on shelves in stores.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Aug 5, 2026
AI Summary
Q2 2026

Outlook cut: USANA lowered its full-year fiscal 2026 outlook, mainly because Hiya’s direct-to-consumer business is facing a tougher, more expensive digital marketing environment and Rise Wellness is seeing lower near-term sales.

Core business steady: Management said the core nutrition business remains stable and is performing in line with expectations, with Greater China showing renewed strength.

Charges hit earnings: The quarter included a preliminary $29 million non-cash goodwill impairment charge tied to Hiya and $9 million of income tax expense on a pre-tax loss of $19 million.

Hiya shift: Hiya is still growing through Target, Canada, the U.K., Amazon, TikTok, and more retail expansion, but subscription growth has been pressured by Meta ad changes and higher customer acquisition costs.

Rise disruption: A packaging issue temporarily disrupted Rise Wellness, but management said the issue is resolved and the brand still has long-term momentum, including a planned new Protein Pop launch in the third quarter.

Balance sheet: The company ended the quarter with $169 million in cash, 0 debt, and $20 million of free cash flow, giving it room to keep investing in its transformation.

Key Financials
Goodwill impairment charge
$29 million
Income tax expense
$9 million
Pre-tax loss
$19 million
Cash
$169 million
Free cash flow
$20 million
Top line impact from Rise disruption
$30 million to $40 million
Margin pressure from Rise disruption
$4 million to $5 million
Retail doors for Rise Wellness
over 4,000
Earnings Call Recording
Other Earnings Calls

Management

Mr. Kevin G. Guest
Executive Chairman
No Bio Available
Mr. Jim Brown
CEO & President
No Bio Available
Mr. G. Douglas Hekking
Chief Financial Officer
No Bio Available
Mr. Walter Noot
Chief Operating Officer
No Bio Available
Mr. P. Joshua Foukas J.D.
Chief Legal Officer, General Counsel & Corporate Secretary
No Bio Available
Mr. Daniel A. Macuga Jr.
Chief Communications & Marketing Officer
No Bio Available
Dr. Myron W. Wentz Ph.D.
Founder & Chairman Emeritus
No Bio Available
Dr. John Cuomo
Executive Director of Product Development & Technology
No Bio Available
Dr. Robert A. Sinnott M.N.S., Ph.D.
Chief Scientific Officer
No Bio Available
Peter Benedict
Chief Information Officer
No Bio Available

Contacts

Address
UTAH
Salt Lake City
3838 West Parkway Blvd.
Contacts
+18019547100
www.usana.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett